Amarin Corp Plcuk (AMRN) Preferred Shares (2015 - 2020)
Amarin Corp Plc\Uk (AMRN) posted quarterly Preferred Shares of $5.4 million for Q3 2020, down 75.13% year-over-year from $21.8 million in Q4 2019, and down 24.17% quarter-over-quarter from $7.2 million in Q2 2020.
Amarin Corp Plcuk (AMRN) Preferred Shares (2015 - 2020) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Preferred Shares for 6 consecutive years, with $5.4 million the latest figure, recorded in Q3 2020.
- In Q3 2020, Preferred Shares fell 75.13% year-over-year to $5.4 million; the TTM figure through Sep 2020 stood at $5.4 million (down 75.13% YoY), while the FY2019 annual figure was $21.8 million, changed 0.0% from the prior year.
- Preferred Shares eased to $5.4 million in Q3 2020 per AMRN's latest filing, from $7.2 million in the prior quarter.
- Across five years, Preferred Shares topped out at $24.4 million in Q1 2016 and bottomed at $5.4 million in Q3 2020.
- Historically, Preferred Shares has averaged $21.5 million across 5 years, with a median of $24.4 million in 2016.
- Annual changes were most pronounced in 2016 — Preferred Shares increased 13.98% — and 2020, when it plunged 75.13%.
- Amarin Corp Plc\Uk's Preferred Shares stood at $24.4 million in 2016, then changed by 0.0% to $24.4 million in 2017, then retreated by 10.32% to $21.8 million in 2018, then changed by 0.0% to $21.8 million in 2019, then plunged by 75.13% to $5.4 million in 2020.
- Business Quant data shows AMRN's Preferred Shares at $5.4 million in Q3 2020, $7.2 million in Q2 2020, and $21.8 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | - |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 5.43 Mn |
| Jun 30, 2020 | 7.17 Mn |
| Mar 31, 2020 | 21.85 Mn |
| Dec 31, 2019 | 21.85 Mn |
| Sep 30, 2019 | 21.85 Mn |
| Jun 30, 2019 | 21.85 Mn |
| Mar 31, 2019 | 21.85 Mn |
| Dec 31, 2018 | 21.85 Mn |
| Sep 30, 2018 | 21.85 Mn |
| Jun 30, 2018 | 24.36 Mn |
| Mar 31, 2018 | 24.36 Mn |
| Dec 31, 2017 | 24.36 Mn |
| Sep 30, 2017 | 24.36 Mn |
| Jun 30, 2017 | 24.36 Mn |
| Mar 31, 2017 | 24.36 Mn |
| Dec 31, 2016 | 24.36 Mn |
| Sep 30, 2016 | 24.36 Mn |
| Jun 30, 2016 | 24.36 Mn |
| Mar 31, 2016 | 24.36 Mn |
| Dec 31, 2015 | 24.36 Mn |